cp wire

CP Wire Articles

Cedilla Therapeutics Adds Three Veterans to Enhance Discovery

Cedilla Therapeutics  announced on 6/28/2018 the appointment of three vice presidents with extensive experience in drug discovery to advance the company’s mission of harnessing existing protein... read more

Thu, 06/28/18 - 09:05 am
Microbiome report for week ending 6-24-18

Some important/interesting microbiome related news for the week ending 6-24-18:

Axial Biotherapeutics and the... read more

Wed, 06/27/18 - 07:51 pm
FDA Grants Orphan Drug Status for Cannabidiol in the Treatment of Autoimmune Hepatitis

Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) announcedon 6/27/2018 that the U.S. Food and Drug Administration (“FDA”) has granted orphan drug designation for cannabidiol (“CBD”) in the... read more

Wed, 06/27/18 - 10:07 am
FDA Grants Priority Review for Pfizer’s Glasdegib in Acute Myeloid Leukemia
  • Glasdegib combined with chemotherapy almost doubled overall survival compared to chemotherapy alone
  • PDUFA goal date is set in December of 2018
  • Ph III trials began enrolling... read more
Wed, 06/27/18 - 09:49 am
Purdue Pharma Completes Ph I for Oncology Therapy Candidate

Purdue Pharma announced on 6/27/2018 successful completion of a first-in-human Phase 1 dose escalation study of tinostamustine in patients with relapsed or refractory hematological malignancies... read more

Wed, 06/27/18 - 09:33 am

Pages